Written and maintained by CASRAI Editorial Board
Last updated
Short Answer
Selected reaction monitoring (SRM) is a targeted mass spectrometry method operating on triple quadrupole instruments. The first mass analyzer selects a specific precursor ion, the collision cell fragments it, and the final analyzer detects a designated product ion. This two-stage mass filter removes background noise, enabling reproducible, absolute quantification across four to five orders of dynamic range in complex matrices.
Definition and Scope of Selected Reaction Monitoring
According to IUPAC mass spectrometry recommendations (Murray et al., 2013), Selected Reaction Monitoring is tandem mass spectrometry acquisition where a precursor ion of a specific mass-to-charge ratio (m/z) is selected in the first stage, undergoes fragmentation, and a designated product ion is selected in the second stage for detection. The coordinated precursor m/z and product m/z pair is termed a transition.
In bioanalytical facilities, SRM provides targeted quantification for peptides, metabolites, and small-molecule drugs. Unlike untargeted discovery workflows, SRM monitors only predefined targets, yielding attomole-level limits of detection and high reproducibility in complex biological fluids.
What Is Multiple Reaction Monitoring (MRM)?
Multiple reaction monitoring (MRM) is the application of SRM to monitor multiple precursor-to-product transitions sequentially or concurrently within a single chromatographic run. In targeted proteomics and pharmacokinetic assays, researchers monitor two to four transitions per target molecule to quantify abundance and confirm analyte identity simultaneously.
How Selected Reaction Monitoring Works in Practice
SRM is conducted on a triple quadrupole (QqQ) mass spectrometer consisting of three sequential stages:
- First Quadrupole (Q1): Filters ions by mass-to-charge ratio at unit mass resolution (~0.7 Da FWHM), transmitting only target precursor ions while deflecting background matrix ions.
- Collision Cell (q2): An RF-only multipole cell containing inert collision gas (argon or nitrogen). Precursor ions undergo collision-induced dissociation (CID) to yield characteristic fragment ions.
- Third Quadrupole (Q3): Operates as a second mass filter, transmitting only pre-selected product ions to the detector.
Dual-stage mass filtering eliminates non-specific chemical background noise, yielding high signal-to-noise ratios in biological extracts.
Transition Selection and Stable Isotope Standards
Assay design targets proteotypic peptides—unambiguous sequences 7 to 25 amino acids long uniquely identifying the target protein (Picotti & Aebersold, 2012). For each peptide, researchers configure:
- Quantifier Transition: The most intense, interference-free fragment ion (typically a y- or b-type ion with m/z greater than the precursor), used for concentration calculation.
- Qualifier Transitions: One to three secondary fragment ions monitored in parallel. Relative intensity ratios between quantifier and qualifier transitions must remain constant (within ±20% to 30%) across samples to verify analyte identity.
Absolute quantification relies on stable isotope dilution. Synthetic peptide standards incorporating heavy stable isotopes (13C and 15N labeled lysine or arginine) are spiked into samples at known concentrations. Because heavy standards share identical chromatographic retention and ionization efficiency with endogenous targets, the light-to-heavy peak area ratio corrects for sample loss and ionization suppression.
Types and Related Concepts: SRM vs. PRM
While SRM on triple quadrupole instruments is the established standard for targeted bioanalysis, high-resolution instruments enable Parallel Reaction Monitoring (PRM). Core facilities evaluate the tradeoffs between these techniques when establishing targeted workflows.
| Analytical Feature | Selected Reaction Monitoring (SRM / MRM) | Parallel Reaction Monitoring (PRM) |
|---|---|---|
| Instrument Architecture | Triple Quadrupole (QqQ) or hybrid QTRAP | Quadrupole-Orbitrap or Quadrupole-Time-of-Flight (Q-TOF) |
| Precursor Selection (MS1) | Quadrupole filter at unit mass resolution (~0.7 Da) | Quadrupole filter with narrow window (0.4 to 2.0 Da) |
| Product Ion Detection (MS2) | Quadrupole filters one pre-selected fragment at a time | High-resolution analyzer detects all product ions in parallel |
| Mass Resolving Power | Unit resolution (R ~ 1,000 to 2,000) | High resolution (R = 17,500 to 70,000+ at m/z 200) |
| Mass Extraction Tolerance | Unit mass (~0.7 Da window) | Narrow accurate mass window (5 to 10 ppm) |
| Method Development | Requires empirical transition selection and collision energy tuning | Requires precursor selection; fragment ions extracted post-acquisition |
| Post-Acquisition Flexibility | None: Unselected transitions cannot be recovered | High: Full MS/MS spectra allow retrospective extraction |
As documented by Peterson et al. (2012), PRM provides comparable quantitative limits of detection and dynamic range to triple quadrupole SRM while utilizing high resolving power to separate co-eluting chemical interferences from target transitions. Instrument procurement considerations are reviewed in the QTOF vs. triple quadrupole comparison.
Where It Matters for Labs, Clinics, and Method Decisions
Executing quantitative SRM/MRM assays requires configuring scan parameters to support chromatographic peak reconstruction.
Cycle Time and Dwell Time Budgeting
Accurate chromatographic peak integration requires acquiring 10 to 15 data points across an elution peak (Picotti & Aebersold, 2012). For an HPLC peak eluting over 15 seconds, the total cycle time must remain below 1.0 to 1.5 seconds.
Total cycle time equals the sum of individual transition dwell times (typically 10 to 50 ms) plus inter-scan pause times. To monitor large transition panels without compromising peak sampling, laboratories apply scheduled MRM, restricting transition monitoring to expected retention time windows (±1 to 2 minutes). Scan budgeting equations are described in our guide on optimizing MRM transitions.
CPTAC Assay Validation Tiers
The National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC) defined three validation tiers for targeted assays (Carr et al., 2014):
- Tier 1 (Clinical Diagnostics): Stringent validation requiring authentic reference materials, defined lower limits of quantification, and intra- and inter-day precision demonstrating CV ≤ 15% to 20%.
- Tier 2 (Biological Verification): Standard for research core facilities tracking targets across biological cohorts. Requires stable isotope-labeled standards, verified response curves, and precision with CV ≤ 20% to 25%.
- Tier 3 (Discovery Screening): Early-stage prioritization screening using crude synthetic peptides for relative quantification without full multi-day validation.
For workflow planning across sample preparation and instrument selection, consult our guides on DDA vs. DIA proteomics, foundational proteomics applications, and calculating a relative response factor.
Common Misunderstandings About SRM
- Assuming SRM Discovers Unknown Biomarkers: SRM is strictly hypothesis-driven; the instrument only monitors programmed precursor-product coordinates and cannot detect unpredicted proteins or modifications.
- Equating Unit Mass Resolution with High Mass Accuracy: Nominal unit mass filtering (~0.7 Da) permits isobaric contaminants to pass through Q1 and Q3. Identity verification requires monitoring qualifier transitions and confirming ion abundance ratios.
- Overloading Unscheduled Panels: Monitoring dozens of transitions without retention-time scheduling shortens dwell times or elongates cycle times, resulting in poor peak definition and high measurement variance.
- Relying on a Single Transition: Quantifying from a single transition leaves assays vulnerable to undetected chemical interferences; at least two transitions per analyte are needed to confirm specificity.
Frequently Asked Questions
What is the difference between Selected Reaction Monitoring (SRM) and Multiple Reaction Monitoring (MRM)?
Selected Reaction Monitoring (SRM) designates monitoring a single precursor-to-product ion transition. Multiple Reaction Monitoring (MRM) is the simultaneous or sequential monitoring of multiple transitions within one run. In practice, analytical laboratories use both terms interchangeably when describing targeted triple quadrupole assays.
When should a laboratory choose PRM over SRM?
Parallel Reaction Monitoring (PRM) is favored for complex matrices where unit-resolution instruments encounter isobaric interferences, and during assay development where capturing full-scan MS/MS spectra eliminates upfront product ion tuning.
How many transitions are required per targeted peptide?
Standard protocols and CPTAC guidelines recommend three to five transitions per peptide: one quantifier transition and two to four qualifier transitions. Qualifier-to-quantifier peak area ratios must match reference standards within ±20% to 30% to verify analyte identity.
Why are stable isotope-labeled standards necessary for absolute quantification?
Stable isotope-labeled standards (SIS peptides) possess identical retention times and ionization efficiencies to endogenous targets. Spiking a known concentration controls for operational variability, electrospray ionization suppression, and sample loss.
Sources
- Murray, K. K., Boyd, R. K., Eberlin, M. N., Langley, G. J., Li, L., & Naito, Y. (2013). Definitions of terms relating to mass spectrometry (IUPAC Recommendations 2013). Pure and Applied Chemistry, 85(7), 1515–1609. https://doi.org/10.1351/PAC-REC-06-04-005
- Picotti, P., & Aebersold, R. (2012). Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nature Methods, 9(6), 555–566. https://doi.org/10.1038/nmeth.2015
- Carr, S. A., Abbatiello, S. E., Ackermann, B. L., Borchers, C., Domon, B., Deutsch, E. W., Grant, R. P., Hoofnagle, A. N., Hüttenhain, R., Koomen, J. M., Liebler, D. C., Liu, T., Loriaux, P., Mani, D. R., Neubert, T. A., Paulovich, A. G., Peterman, S., Qin, J., Regnier, F., … Whiteaker, J. R. (2014). Targeted Peptide Measurements in Biology and Medicine: Best Practices for System Development, Use, and Reporting. Molecular & Cellular Proteomics, 13(3), 907–917. https://doi.org/10.1074/mcp.M113.036095
- Peterson, A. C., Russell, J. D., Bailey, D. J., Westphall, M. S., & Coon, J. J. (2012). Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics. Molecular & Cellular Proteomics, 11(11), 1475–1488. https://doi.org/10.1074/mcp.O112.020131
